;PMID: 9756770
;source_file_630.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..52] = [t:0..52]
;1)sentence:[e:58..112] = [t:58..112]
;2)section:[e:116..219] = [t:116..219]
;3)section:[e:223..378] = [t:223..378]
;4)sentence:[e:382..487] = [t:382..487]
;5)sentence:[e:488..708] = [t:488..708]
;6)sentence:[e:709..952] = [t:709..952]
;7)sentence:[e:953..1173] = [t:953..1173]
;8)sentence:[e:1174..1287] = [t:1174..1287]
;9)sentence:[e:1288..1416] = [t:1288..1416]
;10)sentence:[e:1417..1531] = [t:1417..1531]
;11)sentence:[e:1532..1715] = [t:1532..1715]
;12)section:[e:1719..1763] = [t:1719..1763]
;Token/POS Errors
;ERROR_POS mismatch [41..43] t:token e:CD 10

;section 0 Span:0..52
;Antimicrob Agents Chemother. 1998 Oct;42(10):2645-9.
(SEC
  (FRAG (NNP:[0..10] Antimicrob) (NNPS:[11..17] Agents) (NNP:[18..27] Chemother)
        (.:[27..28] .) (CD:[29..33] 1998) (JJ:[34..39] Oct;4) (CD:[39..40] 2)
        (NN:[40..41] -LRB-) (token:[41..43] 10) (-RRB-:[43..44] -RRB-)
        (::[44..45] :) (CD:[45..48] 264) (CD:[48..51] 5-9) (.:[51..52] .)))

;sentence 1 Span:58..112
;Mechanism of fluconazole resistance in Candida krusei.
;[71..82]:substance:"fluconazole"
(SENT
  (NP-HLN
    (NP (NN:[58..67] Mechanism))
    (PP (IN:[68..70] of)
      (NP (NN:[71..82] fluconazole) (NN:[83..93] resistance)))
    (PP-LOC (IN:[94..96] in)
      (NP (NNP:[97..104] Candida) (NNP:[105..111] krusei)))
    (.:[111..112] .)))

;section 2 Span:116..219
;Orozco AS, Higginbotham LM, Hitchcock CA, Parkinson T, Falconer D, Ibrahim
;AS,  Ghannoum MA, Filler SG.
(SEC
  (FRAG (NNP:[116..122] Orozco) (NNP:[123..125] AS) (,:[125..126] ,)
        (NNP:[127..139] Higginbotham) (NNP:[140..142] LM) (,:[142..143] ,)
        (NNP:[144..153] Hitchcock) (NNP:[154..156] CA) (,:[156..157] ,)
        (NNP:[158..167] Parkinson) (NNP:[168..169] T) (,:[169..170] ,)
        (NNP:[171..179] Falconer) (NNP:[180..181] D) (,:[181..182] ,)
        (NNP:[183..190] Ibrahim) (NNP:[191..193] AS) (,:[193..194] ,)
        (NNP:[196..204] Ghannoum) (NNP:[205..207] MA) (,:[207..208] ,)
        (NNP:[209..215] Filler) (NNP:[216..219] SG.)))

;section 3 Span:223..378
;St. John's Cardiovascular Research Center, Division of Infectious Diseases, 
;Harbor-UCLA Research and Education Institute, Torrance, California 90502,
;USA.
(SEC
  (FRAG (NNP:[223..225] St) (,:[225..226] .) (NNP:[227..231] John)
        (POS:[231..233] 's) (NNP:[234..248] Cardiovascular)
        (NNP:[249..257] Research) (NNP:[258..264] Center) (,:[264..265] ,)
        (NNP:[266..274] Division) (IN:[275..277] of) (NNP:[278..288] Infectious)
        (NNP:[289..297] Diseases) (,:[297..298] ,) (NNP:[300..305] Harbo)
        (NNP:[305..311] r-UCLA) (NNP:[312..320] Research) (CC:[321..324] and)
        (NNP:[325..334] Education) (NNP:[335..344] Institute) (,:[344..345] ,)
        (NNP:[346..354] Torrance) (,:[354..355] ,) (NNP:[356..366] California)
        (CD:[367..372] 90502) (,:[372..373] ,) (NNP:[374..377] USA)
        (.:[377..378] .)))

;sentence 4 Span:382..487
;The mechanisms of fluconazole resistance in three clinical isolates of
;Candida  krusei were investigated.
;[400..411]:substance:"fluconazole"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[382..385] The) (NNS:[386..396] mechanisms))
      (PP (IN:[397..399] of)
        (NP (NN:[400..411] fluconazole) (NN:[412..422] resistance)))
      (PP-LOC (IN:[423..425] in)
        (NP
          (NP (CD:[426..431] three) (JJ:[432..440] clinical)
              (NNS:[441..449] isolates))
          (PP (IN:[450..452] of)
            (NP (NNP:[453..460] Candida) (NNP:[462..468] krusei))))))
    (VP (VBD:[469..473] were)
      (NP (VBN:[474..486] investigated)
        (NP-1 (-NONE-:[486..486] *))))
    (.:[486..487] .)))

;sentence 5 Span:488..708
;Analysis of sterols of organisms grown in the absence  and presence of
;fluconazole demonstrated that the predominant sterol of C.  krusei is
;ergosterol and that fluconazole inhibits 14alpha-demethylase in this 
;organism.
;[500..507]:substance:"sterols"
;[559..570]:substance:"fluconazole"
;[605..611]:substance:"sterol"
;[629..639]:substance:"ergosterol"
;[649..660]:substance:"fluconazole"
;[670..689]:substance:"14alpha-demethylase"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[488..496] Analysis))
      (PP (IN:[497..499] of)
        (NP
          (NP (NNS:[500..507] sterols))
          (PP (IN:[508..510] of)
            (NP
              (NP (NNS:[511..520] organisms))
              (VP (VBN:[521..526] grown)
                (NP (-NONE-:[526..526] *))
                (PP (IN:[527..529] in)
                  (NP
                    (NP (DT:[530..533] the) (NN:[534..541] absence)
                        (CC:[543..546] and) (NN:[547..555] presence))
                    (PP (IN:[556..558] of)
                      (NP (NN:[559..570] fluconazole)))))))))))
    (VP (VBD:[571..583] demonstrated)
      (SBAR
        (SBAR (IN:[584..588] that)
          (S
            (NP-SBJ
              (NP (DT:[589..592] the) (JJ:[593..604] predominant)
                  (NN:[605..611] sterol))
              (PP (IN:[612..614] of)
                (NP (NNP:[615..617] C.) (NNP:[619..625] krusei))))
            (VP (VBZ:[626..628] is)
              (NP-PRD (NN:[629..639] ergosterol)))))
        (CC:[640..643] and)
        (SBAR (IN:[644..648] that)
          (S
            (NP-SBJ (NN:[649..660] fluconazole))
            (VP (VBZ:[661..669] inhibits)
              (NP (NN:[670..689] 14alpha-demethylase))
              (PP (IN:[690..692] in)
                (NP (DT:[693..697] this) (NN:[699..707] organism))))))))
    (.:[707..708] .)))

;sentence 6 Span:709..952
;The 14alpha-demethylase activity in cell extracts of C. krusei was 16-  to
;46-fold more resistant to inhibition by fluconazole than was 
;14alpha-demethylase activity in cell extracts of two fluconazole-susceptible 
;strains of Candida albicans.
;[713..732]:substance:"14alpha-demethylase"
;[776..791]:quantitative-value:"16-  to 46-fold"
;[824..835]:substance:"fluconazole"
;[846..865]:substance:"14alpha-demethylase"
;[899..910]:substance:"fluconazole"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[709..712] The) (NN:[713..732] 14alpha-demethylase)
          (NN:[733..741] activity))
      (PP-LOC (IN:[742..744] in)
        (NP
          (NP (NN:[745..749] cell) (NNS:[750..758] extracts))
          (PP (IN:[759..761] of)
            (NP (NNP:[762..764] C.) (NNP:[765..771] krusei))))))
    (VP (VBD:[772..775] was)
      (ADJP-PRD
        (ADJP
          (ADVP
            (QP (CD:[776..778] 16) (HYPH:[778..779] -) (TO:[781..783] to)
                (CD:[784..786] 46))
            (HYPH:[786..787] -) (RB:[787..791] fold))
          (RBR:[792..796] more) (JJ:[797..806] resistant)
          (PP (TO:[807..809] to)
            (NP
              (NP (NN:[810..820] inhibition))
              (PP (IN:[821..823] by)
                (NP (NN:[824..835] fluconazole))))))
        (PP (IN:[836..840] than)
          (SINV (VBD:[841..844] was)
            (NP-SBJ
              (NP (NN:[846..865] 14alpha-demethylase) (NN:[866..874] activity))
              (PP-LOC (IN:[875..877] in)
                (NP
                  (NP (NN:[878..882] cell) (NNS:[883..891] extracts))
                  (PP (IN:[892..894] of)
                    (NP
                      (NP (CD:[895..898] two)
                        (ADJP (NN:[899..910] fluconazole) (HYPH:[910..911] -)
                              (JJ:[911..922] susceptible))
                        (NNS:[924..931] strains))
                      (PP (IN:[932..934] of)
                        (NP (NNP:[935..942] Candida) (NNP:[943..951] albicans))))))))
            (ADJP-PRD (-NONE-:[951..951] *?*))))))
    (.:[951..952] .)))

;sentence 7 Span:953..1173
;Comparing the carbon monoxide difference spectra of  microsomes from C.
;krusei with those of microsomes from C. albicans indicated  that the total
;cytochrome P-450 content of C. krusei is similar to that of C.  albicans.
;[967..982]:substance:"carbon monoxide"
;[1100..1116]:cyp450:"cytochrome P-450"
(SENT
  (S
    (S-NOM-SBJ
      (NP-SBJ (-NONE-:[953..953] *))
      (VP (VBG:[953..962] Comparing)
        (NP
          (NP (DT:[963..966] the)
            (NML (NN:[967..973] carbon) (NN:[974..982] monoxide))
            (NN:[983..993] difference) (NNS:[994..1001] spectra))
          (PP (IN:[1002..1004] of)
            (NP
              (NP (NNS:[1006..1016] microsomes))
              (PP (IN:[1017..1021] from)
                (NP (NNP:[1022..1024] C.) (NNP:[1025..1031] krusei))))))
        (PP-CLR (IN:[1032..1036] with)
          (NP
            (NP (DT:[1037..1042] those))
            (PP (IN:[1043..1045] of)
              (NP
                (NP (NNS:[1046..1056] microsomes))
                (PP (IN:[1057..1061] from)
                  (NP (NNP:[1062..1064] C.) (NNP:[1065..1073] albicans)))))))))
    (VP (VBD:[1074..1083] indicated)
      (SBAR (IN:[1085..1089] that)
        (S
          (NP-SBJ
            (NP (DT:[1090..1093] the)
              (NML (JJ:[1094..1099] total)
                 (NN:[1100..1110] cytochrome) (NN:[1111..1116] P-450))
              (NN:[1117..1124] content))
            (PP (IN:[1125..1127] of)
              (NP (NNP:[1128..1130] C.) (NNP:[1131..1137] krusei))))
          (VP (VBZ:[1138..1140] is)
            (ADJP-PRD (JJ:[1141..1148] similar)
              (PP (TO:[1149..1151] to)
                (NP
                  (NP (DT:[1152..1156] that))
                  (PP (IN:[1157..1159] of)
                    (NP (NNP:[1160..1162] C.) (NNP:[1164..1172] albicans))))))))))
    (.:[1172..1173] .)))

;sentence 8 Span:1174..1287
;The Soret absorption maximum in these spectra was located at 448 nm  for C.
;krusei and at 450 nm for C. albicans.
;[1235..1238]:quantitative-value:"448"
;[1239..1241]:quantitative-units:"nm"
;[1264..1267]:quantitative-value:"450"
;[1268..1270]:quantitative-units:"nm"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1174..1177] The) (NNP:[1178..1183] Soret)
          (NN:[1184..1194] absorption) (NN:[1195..1202] maximum))
      (PP-LOC (IN:[1203..1205] in)
        (NP (DT:[1206..1211] these) (NNS:[1212..1219] spectra))))
    (VP (VBD:[1220..1223] was)
      (VP
        (VP=1 (VBN:[1224..1231] located)
          (PP-LOC=2 (IN:[1232..1234] at)
            (NP (CD:[1235..1238] 448) (NN:[1239..1241] nm)))
          (PP=3 (IN:[1243..1246] for)
            (NP (NNP:[1247..1249] C.) (NNP:[1250..1256] krusei))))
        (CC:[1257..1260] and)
        (VP=1
          (PP-LOC=2 (IN:[1261..1263] at)
            (NP (CD:[1264..1267] 450) (NN:[1268..1270] nm)))
          (PP=3 (IN:[1271..1274] for)
            (NP (NNP:[1275..1277] C.) (NNP:[1278..1286] albicans))))))
    (.:[1286..1287] .)))

;sentence 9 Span:1288..1416
;Finally, the fluconazole  accumulation of two of the C. krusei isolates was
;similar to if not greater than  that of C. albicans.
;[1301..1312]:substance:"fluconazole"
(SENT
  (S
    (ADVP (RB:[1288..1295] Finally))
    (,:[1295..1296] ,)
    (NP-SBJ
      (NP (DT:[1297..1300] the) (NN:[1301..1312] fluconazole)
          (NN:[1314..1326] accumulation))
      (PP (IN:[1327..1329] of)
        (NP
          (NP (CD:[1330..1333] two))
          (PP (IN:[1334..1336] of)
            (NP (DT:[1337..1340] the)
              (NP (NNP:[1341..1343] C.) (NNP:[1344..1350] krusei))
              (NNS:[1351..1359] isolates))))))
    (VP (VBD:[1360..1363] was)
      (ADJP-PRD
        (ADJP (JJ:[1364..1371] similar)
          (PP (TO:[1372..1374] to)
            (NP-1 (-NONE-:[1374..1374] *RNR*))))
        (CONJP (IN:[1375..1377] if) (RB:[1378..1381] not))
        (ADJP (JJR:[1382..1389] greater)
          (PP (IN:[1390..1394] than)
            (NP-1 (-NONE-:[1394..1394] *RNR*))))
        (NP-1
          (NP (DT:[1396..1400] that))
          (PP (IN:[1401..1403] of)
            (NP (NNP:[1404..1406] C.) (NNP:[1407..1415] albicans))))))
    (.:[1415..1416] .)))

;sentence 10 Span:1417..1531
;Thus, there are significant qualitative differences between  the
;14alpha-demethylase of C. albicans and C. krusei.
;[1482..1501]:substance:"14alpha-demethylase"
(SENT
  (S
    (ADVP (RB:[1417..1421] Thus))
    (,:[1421..1422] ,)
    (NP-SBJ (EX:[1423..1428] there))
    (VP (VBP:[1429..1432] are)
      (NP-PRD
        (NP (JJ:[1433..1444] significant) (JJ:[1445..1456] qualitative)
            (NNS:[1457..1468] differences))
        (PP (IN:[1469..1476] between)
          (NP
            (NP (DT:[1478..1481] the) (NN:[1482..1501] 14alpha-demethylase))
            (PP (IN:[1502..1504] of)
              (NP
                (NP (NNP:[1505..1507] C.) (NNP:[1508..1516] albicans))
                (CC:[1517..1520] and)
                (NP (NNP:[1521..1523] C.) (NNP:[1524..1530] krusei))))))))
    (.:[1530..1531] .)))

;sentence 11 Span:1532..1715
;In addition, fluconazole  resistance in these strains of C. krusei appears to
;be mediated predominantly by  a reduced susceptibility of 14alpha-demethylase
;to inhibition by this drug.
;[1545..1556]:substance:"fluconazole"
;[1668..1687]:substance:"14alpha-demethylase"
;[1710..1714]:substance:"drug"
(SENT
  (S
    (PP (IN:[1532..1534] In)
      (NP (NN:[1535..1543] addition)))
    (,:[1543..1544] ,)
    (NP-SBJ-1
      (NP (NN:[1545..1556] fluconazole) (NN:[1558..1568] resistance))
      (PP-LOC (IN:[1569..1571] in)
        (NP
          (NP (DT:[1572..1577] these) (NNS:[1578..1585] strains))
          (PP (IN:[1586..1588] of)
            (NP (NNP:[1589..1591] C.) (NNP:[1592..1598] krusei))))))
    (VP (VBZ:[1599..1606] appears)
      (S
        (NP-SBJ-1 (-NONE-:[1606..1606] *))
        (VP (TO:[1607..1609] to)
          (VP (VB:[1610..1612] be)
            (VP (VBN:[1613..1621] mediated)
              (NP-1 (-NONE-:[1621..1621] *))
              (ADVP (RB:[1622..1635] predominantly))
              (PP (IN:[1636..1638] by)
                (NP-LGS
                  (NP (DT:[1640..1641] a) (JJ:[1642..1649] reduced)
                      (NN:[1650..1664] susceptibility))
                  (PP (IN:[1665..1667] of)
                    (NP (NN:[1668..1687] 14alpha-demethylase)))
                  (PP (TO:[1688..1690] to)
                    (NP
                      (NP (NN:[1691..1701] inhibition))
                      (PP (IN:[1702..1704] by)
                        (NP (DT:[1705..1709] this) (NN:[1710..1714] drug))))))))))))
    (.:[1714..1715] .)))

;section 12 Span:1719..1763
;PMID: 9756770 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1719..1723] PMID) (::[1723..1724] :) (CD:[1725..1732] 9756770)
        (NN:[1733..1734] -LSB-) (NNP:[1734..1740] PubMed) (::[1741..1742] -)
        (NN:[1743..1750] indexed) (IN:[1751..1754] for)
        (NNP:[1755..1763] MEDLINE-RSB-)))
